1 Unless otherwise noted, the business address of each of the directors and officers is 167 N. Green Street, 9th Floor, Chicago, Illinois 60607. The table excludes (i) the contingent right of Mr. Ramamurthy, Mr. Herb, Mr. Goodson, Mr. Fredman, Ms. Schloss, Ms. Williams and Mr. Ingram to receive, subject to adjustment, 720,561, 41,596, 19,198, 54,394, 6,398, 6,399, and 6,399 shares based on the Company achieving certain trading price targets for its common stock or undergoing a change of control (“CCC Earnout Shares”), respectively and (ii) shares of common stock underlying performance restricted stock units, which represent a contingent right to receive a number of shares of common stock, cash or a combination thereof based on total shareholder return realized by stockholders over a specified period.
2 Includes (i) 23,114,393 shares of the common stock and (ii) 13,172,320 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025. As a result of Mr. Ramamurthy’s commitment to exercise such options solely through ‘cashless’ means he does not have a right to acquire the gross number of shares underlying such stock options pursuant to Rule 30d-3(d)(1) within 60 days of April 1, 2025.
3 Includes (i) 361,032 shares of the common stock and (ii) 1,106,788 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025.
4 Includes (i) 187,697 shares of the common stock and (ii) 419,743 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025.
5 Includes (i) 272,280 shares of the common stock and (ii) 340,550 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025.
6 Includes 128,615 shares of the common stock.
7 Includes (i) 54,047 shares of the common stock; (ii) 136,220 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025 and (iii) 23,565 shares of the common stock underlying RSUs that will vest within 60 days of April 1, 2025.
8 Includes (i) 54,047 shares of the common stock and (ii) 23,565 shares of the common stock underlying RSUs that will vest within 60 days of April 1, 2025.
9 Includes (i) 54,135 shares of the common stock; (ii) 136,220 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025 and (iii) 21,423 shares of the common stock underlying RSUs that will vest within 60 days of April 1, 2025.
10 Includes (i) 100,000 shares of the common stock and (ii) 13,429 shares of the common stock underlying RSUs that will vest within 60 days of April 1, 2025.
11 Includes (i) 25,143,411 shares of the common stock; (ii) 15,411,841 shares of the common stock underlying stock options that are currently exercisable or that will become exercisable within 60 days of April 1, 2025 and (iii) 81,982 shares of the common stock underlying RSUs that will vest within 60 days of April 1, 2025.
12 Based solely on an amendment to Schedule 13D filed by Advent International, L.P. and its affiliates on April 2, 2025, Cypress Investor Holdings, L.P. (“Cypress Investor”), GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Advent International GPE VIII-C Limited Partnership (“Advent International VIII-C”) are the record holders of 71,403,848 shares, 23,680,335 shares and 2,258,343 shares of common stock, respectively. Cypress Investment GP, LLC is the general partner of Cypress Investor. Cypress Investor is beneficially owned by Advent International GPE VIII Limited Partnership (“Advent International VIII”), Advent International GPE VIII-A Limited Partnership (“Advent International VIII-A”), Advent International GPE VIII-B-1 Limited Partnership (“Advent International VIII-B-1”), Advent International GPE VIII-B-2 Limited Partnership (“Advent International VIII-B-2”), Advent International GPE VIII-B-3 Limited Partnership (“Advent International VIII-B-3”), Advent International GPE VIII-B Limited Partnership (“Advent International VIII-B”), Advent International GPE VIII-D Limited Partnership (“Advent International VIII-D”), Advent International GPE VIII-E